Table 2.
Characteristics of Neurofibroma Subtypes Defined by the WHO
Subtype | Location | Relation to NF1 | Malignant Potential | Comments |
---|---|---|---|---|
Localized cutaneous | Skin (dermis and subcutaneous) | 10% NF1-associated, 90% sporadic | None | Most common subtype. In NF1, may be overlain by café-au-lait macules |
Diffuse cutaneous | Skin (dermis and subcutaneous) | 10% NF1-associated, 90% sporadic | Very low, but does occur | Uncommon lesions that present as plaque-like thickenings of skin |
Localized intraneural | Cranial, spinal or autonomic nerves | Can be either sporadic or NF1-associated | Intermediate | Second most common subtype |
Plexiform | Cranial, spinal or autonomic nerve plexuses | Exclusively NF1-associated | Highest | Key diagnostic for NF1 |
Massive soft tissue | Extremities, extensive soft tissue expansion with underlying large nerve | Exclusively NF1-associated | Intermediate, but low clinical impact due to rarity | Least common subtype, also known as elephantiasis neuromatosa |